Although EMPEROR-R enrolled patients with and without type 2 diabetes, the primary outcome of the trial (a composite of CV death and hospitalization for HF) was almost identical in both groups, suggesting that the different population didnt affect the results, at least for the primary outcome
Typical applications include: Obesity and Weight-Management Models : Evaluating how dual amylin + GLP-1 signaling influences body weight, waist measures, and energy intake in animal models and clinical research settings
In most human cells, it is abundant, measuring up to 5 millimoles (an international unit in chemistry/physics)
For injectables, use subcutaneous routes with rotation
That's what happened in the case of new weight-loss drugs, known as GLP-1 agonists, that have exploded in popularity in the past couple of years
Hyperthermia in Cancer Treatment